Statements (13)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
Hallucinogen |
gptkbp:activeIngredient |
gptkb:lysergic_acid_diethylamide
|
gptkbp:clinicalTrialPhase |
Phase 2
|
gptkbp:developedBy |
MindMed
|
gptkbp:has_salt_form |
D-tartrate
|
https://www.w3.org/2000/01/rdf-schema#label |
MM-120 (LSD D-tartrate)
|
gptkbp:investigatedBy |
gptkb:generalized_anxiety_disorder
anxiety disorders |
gptkbp:relatedTo |
LSD
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:bfsParent |
gptkb:Mind_Medicine
|
gptkbp:bfsLayer |
7
|